查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1652684

化妆品胜□製造市场：全球产业分析、市场规模、占有率、成长、趋势与未来预测（2025-2032）

Cosmetic Peptide Manufacturing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 224 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球化妆品胜□製造市场的综合报告。该报告对市场推动因素、趋势、机会、推动因素和课题等关键市场动态进行了全面的评估，并对市场结构提供了详细的见解。本研究报告提供了独家数据和统计数据，概述了 2025 年至 2032 年全球化妆品胜□製造市场的预期成长轨迹。

主要的洞察

  • 化妆品胜□製造市场规模（2025 年）：2.599 亿美元
  • 预测市场规模（价值基础，2032 年）：4.069 亿美元
  • 全球市场成长率（CAGR，2025-2032）：6.60%

化妆品胜□製造市场：分析范围

化妆品胜□是一种生物活性成分，在促进皮肤健康、减少老化迹象和促进年轻外表方面发挥重要作用。这些胜□通常被添加到乳霜、乳液和精华液等护肤产品中，以提供抗衰老、紧緻和恢復活力的功效。该市场迎合各种化妆品製造商，包括全球护肤品牌、皮肤病诊所和美容院。化妆品胜□製造市场的成长得益于对有效抗衰老解决方案的需求不断增长、对基于胜□的护肤产品的认识不断提高以及胜□合成和製造技术的不断进步。

市场成长动力：

全球化妆品胜□製造市场受到几个关键因素的推动，包括消费者对抗老化产品的需求不断增加以及对基于胜□的皮肤护理解决方案的偏好日益增加。人们越来越意识到胜□在改善皮肤弹性、减少皱纹和改善整体皮肤外观方面的功效，这极大地促进了对这些成分的需求。此外，胜□合成技术的进步使得生产更有效率、更具成本效益，进而推动了市场的成长。个人化护肤解决方案的日益普及和全球护肤品产业的扩张进一步推动了对高品质化妆品胜□的需求。

市场限制：

儘管成长前景看好，但化妆品胜□製造市场面临着与胜□合成的复杂性、高製造成本和监管障碍相关的课题。胜□的製造过程需要先进的技术和对分子结构的精确控制，因此成本较高。此外，人们对某些胜□的安全性和有效性存在担忧，监管审查可能会延迟新产品进入市场。製造商必须克服这些课题，以保持其□基产品的质量，同时确保遵守严格的法规。

市场机会：

由于技术进步、消费者偏好的不断变化以及对皮肤健康的日益关注，化妆品胜□製造市场提供了巨大的成长机会。开发具有增强的抗衰老和皮肤再生功效的新型胜□为市场参与者扩大其产品组合提供了良好的机会。此外，人们对天然和永续美容产品的日益关注为采用植物源胜□和环保製造流程创造了有利的环境。胜□製造商和化妆品品牌合作开发创新、高性能产品为持续的市场扩张指明了方向。

本报告解答的关键问题

  • 推动全球化妆品胜□製造市场成长的关键因素有哪些？
  • 哪些类型的胜□推动了基于胜□的护肤产品的采用？
  • 胜□合成技术的进步如何改变製造流程和产品供应？
  • 哪些主要公司为化妆品胜□製造市场做出了贡献？他们采用什么策略来维持市场领导地位？
  • 全球化妆品胜□製造市场的新兴趋势和未来前景是什么？

目录

第 1 章执行摘要

第2章 市场概览

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
    • 主要趋势
  • 技术生命週期分析
  • 化妆品胜□製造市场：价值链
    • 原料供应商名单
    • 製造商列表
    • 经销商名单
    • 用途列表
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 宏观经济因素
    • 全球产业展望
    • 全球 GDP 成长前景
    • 全球母公司市场概览
  • 预测因子：相关性和影响力
  • 监管与技术格局

第 3 章全球化妆品胜□製造市场展望：过去（2019-2023 年）与预测（2025-2032 年）

  • 主要亮点
    • 市场规模预测（基于数量）
    • 市场规模与年成长率
    • 绝对的获利机会
  • 市场规模分析与预测（价值基础（百万美元））
    • 过往市场规模分析（2019-2023 年）
    • 当前市场规模预测（2025-2032）
  • 全球化妆品胜□製造市场（按产品）展望
    • 简介/主要发现
    • 按产品划分的历史市场规模表现（价值（百万美元）和数量，2019 年至 2023 年）
    • 按产品划分的当前市场规模预测（价值（百万美元）和数量，2025 年至 2032 年）
      • 信号□
      • 神经传导物质抑制剂
      • 载体胜□
      • 酵素抑制胜□
      • 结构胜□
      • 合成抗菌胜□（Amp）
      • 其他
  • 依产品进行市场吸引力分析
  • 全球化妆品胜□製造市场应用前景
    • 简介/主要发现
    • 按应用划分的历史市场规模表现（价值（百万美元）和数量，2019 年至 2023 年）
    • 按应用划分的当前市场规模预测（价值（百万美元）和数量，2025 年至 2032 年）
      • 抗衰老
      • 眼部护理
      • 防止色素沉着
      • 头髮生长
  • 按应用程式进行市场吸引力分析
  • 全球化妆品胜□製造市场前景（依最终用户）
    • 简介/主要发现
    • 以最终用户划分的历史市场规模表现（价值（百万美元）和数量，2019 年至 2023 年）
    • 按最终用户划分的当前市场规模预测（价值（百万美元）和数量，2025 年至 2032 年）
      • 化妆品製造商
      • 化妆品合约製造商
      • 生物製药业（个人护理）
  • 按最终用户进行市场吸引力分析
第4章 全球化妆品胜□製造市场区域展望
  • 主要亮点
  • 按地区划分的历史市场规模分析（价值（百万美元）和数量，2019 年至 2023 年）
  • 按地区划分的当前市场规模预测（价值（百万美元）和数量，2025 年至 2032 年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区进行市场吸引力分析

第 5 章北美化妆品胜□製造市场展望：历史（2019-2023）与预测（2025-2032）

第 6 章欧洲化妆品胜□製造市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 7 章 东亚化妆品胜□製造市场展望：过去（2019-2023 年）与预测（2025-2032 年）

第 8 章 南亚和大洋洲化妆品胜□製造市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 9 章拉丁美洲化妆品胜□製造市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 10 章中东和非洲化妆品胜□製造市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 11 章 竞争格局

  • 市占率分析（2024年）
  • 市场结构
    • 竞争加剧图：依市场划分
    • 竞争资讯中心
    • 生产能力（表观值）
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Croda International Plc
    • Ashland
    • DSM[Koninklijke DSM NV]
    • Bachem
    • Genscript Biotech Corp
    • BASF SE
    • Geltor
    • The Lubrizol Corporation
    • Symrise
    • Bio basic Inc.
    • Regeron Inc.

第 12 章附录

  • 研究方法
  • 调查前提
  • 缩写和缩写
简介目录
Product Code: PMRREP33714

Persistence Market Research has recently released a comprehensive report on the worldwide market for cosmetic peptide manufacturing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global cosmetic peptide manufacturing market from 2025 to 2032.

Key Insights:

  • Cosmetic Peptide Manufacturing Market Size (2025E): USD 259.9 Million
  • Projected Market Value (2032F): USD 406.9 Million
  • Global Market Growth Rate (CAGR 2025 to 2032):6.60%

Cosmetic Peptide Manufacturing Market - Report Scope:

Cosmetic peptides are bioactive ingredients that play a vital role in enhancing skin health, reducing signs of aging, and promoting a youthful appearance. These peptides are commonly incorporated into skincare products such as creams, lotions, and serums, offering benefits such as anti-aging, firming, and skin rejuvenation. The market caters to various cosmetic manufacturers, including global skincare brands, dermatological clinics, and beauty salons. The growth of the cosmetic peptide manufacturing market is driven by the rising demand for effective anti-aging solutions, increased awareness of peptide-based skincare products, and continuous advancements in peptide synthesis and manufacturing techniques.

Market Growth Drivers:

The global cosmetic peptide manufacturing market is propelled by several key factors, including growing consumer demand for anti-aging products and increased preference for peptide-based skincare solutions. The rising awareness regarding the effectiveness of peptides in improving skin elasticity, reducing wrinkles, and enhancing overall skin appearance contributes significantly to the demand for these ingredients. Additionally, advancements in peptide synthesis technologies, which allow for more efficient and cost-effective production, are supporting market growth. The increasing popularity of personalized skincare solutions and the expansion of the global skincare industry further enhance the demand for high-quality cosmetic peptides.

Market Restraints:

Despite promising growth prospects, the cosmetic peptide manufacturing market faces challenges related to the complexity of peptide synthesis, high production costs, and regulatory hurdles. The process of manufacturing peptides involves sophisticated techniques and precise control over molecular structures, which can be costly. Additionally, there are concerns regarding the safety and efficacy of certain peptides, leading to regulatory scrutiny that can delay market entry for new products. Manufacturers must navigate these challenges to ensure compliance with stringent regulations while maintaining the quality of their peptide-based products.

Market Opportunities:

The cosmetic peptide manufacturing market presents significant growth opportunities driven by technological advancements, evolving consumer preferences, and the growing emphasis on skin health. The development of novel peptides with enhanced anti-aging and skin-rejuvenating properties offers promising opportunities for market players to expand their product portfolios. Furthermore, the increasing focus on natural and sustainable beauty products creates a favorable environment for the introduction of plant-based peptides and eco-friendly manufacturing processes. Collaborations between peptide manufacturers and cosmetic brands to develop innovative, high-performance products present an avenue for continued market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the cosmetic peptide manufacturing market globally?
  • Which types of peptides are driving the adoption of peptide-based skincare products?
  • How are advancements in peptide synthesis technologies reshaping the manufacturing process and product offerings?
  • Who are the key players contributing to the cosmetic peptide manufacturing market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global cosmetic peptide manufacturing market?

Competitive Intelligence and Business Strategy:

Leading players in the global cosmetic peptide manufacturing market, including companies like BASF SE, Evonik Industries, and Givaudan, focus on innovation, product differentiation, and strategic partnerships to maintain a competitive edge. These companies invest in research and development to create advanced peptide formulations that offer superior anti-aging, moisturizing, and skin-smoothing benefits. Collaborations with cosmetic brands and skincare product manufacturers facilitate market penetration and the introduction of cutting-edge peptide-based formulations. Additionally, expanding R&D efforts into sustainable peptide sourcing and eco-friendly manufacturing practices enhances the appeal of these ingredients among environmentally conscious consumers.

Key Companies Profiled:

  • BASF SE
  • Evonik Industries
  • Givaudan
  • DSM Nutritional Products
  • Sederma Inc.
  • Clariant AG
  • Croda International Plc
  • Kobo Products Inc.
  • Peptitec
  • Tri-K Industries, Inc.

Cosmetic Peptide Manufacturing Market Research Segmentation

By Product:

  • Signal Peptides
  • Neurotransmitter Inhibitors
  • Carrier Peptides
  • Enzyme Inhibitor Peptides
  • Structural Peptides
  • Synthetic Antimicrobial Peptides (Amps)

By Application:

  • Anti-Aging
  • Eye Care
  • Anti Pigmentation
  • Hair Growth

By End User:

  • Cosmetic Manufacturers
  • Cosmetic Contract Manufacturers
  • Biopharmaceutical Industries (Personal care)

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cosmetic Peptide Manufacturing Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. Cosmetic Peptide Manufacturing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Cosmetic Peptide Manufacturing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
      • 3.3.3.1. Signal Peptides
      • 3.3.3.2. Neurotransmitter Inhibitors
      • 3.3.3.3. Carrier Peptides
      • 3.3.3.4. Enzyme Inhibitor Peptides
      • 3.3.3.5. Structural Peptides
      • 3.3.3.6. Synthetic Antimicrobial Peptides (Amps)
      • 3.3.3.7. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global Cosmetic Peptide Manufacturing Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
      • 3.5.3.1. Anti-Aging
      • 3.5.3.2. Eye Care
      • 3.5.3.3. Anti-Pigmentation
      • 3.5.3.4. Hair Growth
  • 3.6. Market Attractiveness Analysis: End User
  • 3.7. Global Cosmetic Peptide Manufacturing Market Outlook: End User
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
      • 3.7.3.1. Cosmetic Manufacturers
      • 3.7.3.2. Cosmetic Contract Manufacturers
      • 3.7.3.3. Biopharmaceutical Industries (Personal care)
  • 3.8. Market Attractiveness Analysis: End User

4. Global Cosmetic Peptide Manufacturing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Application
    • 5.3.4. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 5.5.1. Signal Peptides
    • 5.5.2. Neurotransmitter Inhibitors
    • 5.5.3. Carrier Peptides
    • 5.5.4. Enzyme Inhibitor Peptides
    • 5.5.5. Structural Peptides
    • 5.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 5.5.7. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 5.6.1. Anti-Aging
    • 5.6.2. Eye Care
    • 5.6.3. Anti Pigmentation
    • 5.6.4. Hair Growth
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 5.7.1. Cosmetic Manufacturers
    • 5.7.2. Cosmetic Contract Manufacturers
    • 5.7.3. Biopharmaceutical Industries (Personal care)
  • 5.8. Market Attractiveness Analysis

6. Europe Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Application
    • 6.3.4. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 6.5.1. Signal Peptides
    • 6.5.2. Neurotransmitter Inhibitors
    • 6.5.3. Carrier Peptides
    • 6.5.4. Enzyme Inhibitor Peptides
    • 6.5.5. Structural Peptides
    • 6.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 6.5.7. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 6.6.1. Anti-Aging
    • 6.6.2. Eye Care
    • 6.6.3. Anti Pigmentation
    • 6.6.4. Hair Growth
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 6.7.1. Cosmetic Manufacturers
    • 6.7.2. Cosmetic Contract Manufacturers
    • 6.7.3. Biopharmaceutical Industries (Personal care)
  • 6.8. Market Attractiveness Analysis

7. East Asia Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Application
    • 7.3.4. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 7.5.1. Signal Peptides
    • 7.5.2. Neurotransmitter Inhibitors
    • 7.5.3. Carrier Peptides
    • 7.5.4. Enzyme Inhibitor Peptides
    • 7.5.5. Structural Peptides
    • 7.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 7.5.7. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 7.6.1. Anti-Aging
    • 7.6.2. Eye Care
    • 7.6.3. Anti Pigmentation
    • 7.6.4. Hair Growth
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 7.7.1. Cosmetic Manufacturers
    • 7.7.2. Cosmetic Contract Manufacturers
    • 7.7.3. Biopharmaceutical Industries (Personal care)
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 8.5.1. Signal Peptides
    • 8.5.2. Neurotransmitter Inhibitors
    • 8.5.3. Carrier Peptides
    • 8.5.4. Enzyme Inhibitor Peptides
    • 8.5.5. Structural Peptides
    • 8.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 8.5.7. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 8.6.1. Anti-Aging
    • 8.6.2. Eye Care
    • 8.6.3. Anti Pigmentation
    • 8.6.4. Hair Growth
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 8.7.1. Cosmetic Manufacturers
    • 8.7.2. Cosmetic Contract Manufacturers
    • 8.7.3. Biopharmaceutical Industries (Personal care)
  • 8.8. Market Attractiveness Analysis

9. Latin America Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 9.5.1. Signal Peptides
    • 9.5.2. Neurotransmitter Inhibitors
    • 9.5.3. Carrier Peptides
    • 9.5.4. Enzyme Inhibitor Peptides
    • 9.5.5. Structural Peptides
    • 9.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 9.5.7. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2025 - 2032
    • 9.6.1. Anti-Aging
    • 9.6.2. Eye Care
    • 9.6.3. Anti Pigmentation
    • 9.6.4. Hair Growth
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 9.7.1. Cosmetic Manufacturers
    • 9.7.2. Cosmetic Contract Manufacturers
    • 9.7.3. Biopharmaceutical Industries (Personal care)
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 10.5.1. Signal Peptides
    • 10.5.2. Neurotransmitter Inhibitors
    • 10.5.3. Carrier Peptides
    • 10.5.4. Enzyme Inhibitor Peptides
    • 10.5.5. Structural Peptides
    • 10.5.6. Synthetic Antimicrobial Peptides (Amps)
    • 10.5.7. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application,2025 - 2032
    • 10.6.1. Anti-Aging
    • 10.6.2. Eye Care
    • 10.6.3. Anti Pigmentation
    • 10.6.4. Hair Growth
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 10.7.1. Cosmetic Manufacturers
    • 10.7.2. Cosmetic Contract Manufacturers
    • 10.7.3. Biopharmaceutical Industries (Personal care)
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Neurotransmitter Inhibitors
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Croda International Plc
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Ashland
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. DSM [Koninklijke DSM NV]
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Bachem
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Genscript Biotech Corp
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. BASF SE
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Geltor
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. The Lubrizol Corporation
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Symrise
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bio basic Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Regeron Inc.
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations